Perspective on biotech
|14th September 2017
Biotech companies operate in highly complex markets with extremely challenging regulatory constraints. As a creative marketing consultancy we are well positioned to cut through this noise and tackle challenges from all angles, offering leading strategic and creative solutions.
Ahead of our upcoming report into strategic challenges and opportunities in the sector, we have been speaking to biotech experts to find out their perspective on the state of the industry.
Here we explore some of their enlightening insights and reveal how the definition of biotech is changing as big pharma turns its research and development to biological therapies.
Find out about:
- The emerging technologies revolutionising the biotech industry – from immunotherapy breakthroughs to cutting-edge gene editing techniques
- How to define a biotech company – is the current definition still valid?
- Shaping the future of healthcare – solving four common challenges facing biotech companies today.
Top 5 tips for a multi-indication product launch
|8th July 2020
Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.
If our patients are diverse, why are clinical trials so white?
|22nd June 2020
Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.
How to run an engaging virtual workshop
|15th June 2020
Our strategic consultants give their top tips for running an engaging virtual workshop.